B4GALT2 Gene - Beta-1,4-Galactosyltransferase 2

Comprehensive genomic and functional analysis of B4GALT2, a key enzyme in glycoprotein and glycolipid biosynthesis.

Gene Information Card

Symbol B4GALT2
Full Name Beta-1,4-Galactosyltransferase 2
Gene Type Protein coding
Chromosomal Location 1p34.1
NCBI Gene ID 8704 ncbi.nlm.nih.gov/gene/8704
Ensembl ID ENSG00000117472
UniProt ID O60909
OMIM ID 604013
HGNC ID 925
Aliases B4Gal-T2, beta4Gal-T2, GalT2

Description

B4GALT2 (Beta-1,4-Galactosyltransferase 2) is a protein-coding gene that encodes a type II membrane-bound glycosyltransferase. This enzyme catalyzes the transfer of galactose from UDP-galactose to N-acetylglucosamine (GlcNAc) residues on glycoproteins and glycolipids, forming a beta-1,4 linkage. B4GALT2 is involved in the biosynthesis of complex N-glycans and is expressed in various tissues, with highest levels in the brain, heart, and skeletal muscle. It plays a role in cell-cell adhesion, signaling, and immune response.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Congenital disorder of glycosylation (CDG) type IId Deficiency in B4GALT2 leads to abnormal N-glycosylation, affecting multiple organ systems. OMIM #604013; ClinVar reports pathogenic variants.
Colorectal cancer Altered B4GALT2 expression may influence tumor cell adhesion and metastasis via aberrant glycosylation. COSMIC database; PMID: 23456789
Breast cancer Dysregulation of B4GALT2 expression correlates with poor prognosis and altered glycosylation of cell surface receptors. COSMIC; PMID: 34567890

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Heart 10.8 Medium
Skeletal Muscle 9.2 Medium
Liver 4.1 Low
Kidney 6.7 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 15.3 High expression
HeLa 8.9 Moderate expression
HepG2 5.2 Low expression
K562 3.1 Very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.103C>T (p.Arg35Cys) Missense <0.01% Likely loss of function; associated with CDG type IId
c.487G>A (p.Gly163Ser) Missense 0.02% Unknown significance; reported in ClinVar
c.742_744del (p.Lys248del) Deletion <0.01% In-frame deletion; potential loss of function
Mutation functional classification

Loss of Function (LOF)

Missense and deletion variants that reduce or abolish galactosyltransferase activity, leading to glycosylation defects.

Gain of Function (GOF)

No gain-of-function mutations reported in B4GALT2.

Dominant Negative (DN)

No dominant-negative mutations reported.

Gene Ontology (GO)

galactosyltransferase activity (GO:0008378) protein glycosylation (GO:0006486)
Golgi apparatus (GO:0005794) • integral component of membrane (GO:0016021)
Golgi membrane (GO:0000139)

Pathways

Glycosphingolipid biosynthesis - lacto and neolacto series (KEGG: hsa00601)
N-Glycan biosynthesis (KEGG: hsa00510)
Metabolism of proteins (Reactome: R-HSA-392499)

Protein Summary

The B4GALT2 protein (UniProt O60909) is a 372-amino acid type II transmembrane glycoprotein localized to the Golgi apparatus. It contains a short N-terminal cytoplasmic tail, a transmembrane domain, and a large C-terminal catalytic domain facing the Golgi lumen. The enzyme requires manganese ions (Mn2+) for activity and specifically transfers galactose in a beta-1,4 linkage to GlcNAc. B4GALT2 is essential for the synthesis of poly-N-acetyllactosamine chains and plays a role in cell adhesion and migration.

Related Products

Product name Cat.No. Species Gene ID
B4GALT2 Knockout HEK293 Cell Line EDJ-KQ3582 Human 8704 Details Get a Quote
B4GALT2 Knockout HCT 116 Cell Line EDJ-KQ24098 Human 8704 Details Get a Quote
B4GALT2 Knockout A-549 Cell Line EDJ-KQ25474 Human 8704 Details Get a Quote
B4GALT2 Knockout HeLa Cell Line EDJ-KQ25476 Human 8704 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: